Yosemite

Yosemite operates as a specialized venture capital firm, investing in early-stage biotech and healthcare innovations, with a primary focus on oncology. The firm strategically provides capital and support to companies developing novel solutions for cancer treatment. Its approach identifies and nurtures scientific advancements with significant potential to improve global health outcomes.

Founded by Reed Jobs in 2015, Yosemite emerged from a profound commitment to addressing critical health challenges. Jobs' insight was that focused investment in pioneering medical research could accelerate progress toward rendering cancer a manageable or non-lethal condition. This vision directly informs the firm's specialized investment strategy.

Yosemite backs innovative startups in the healthcare and biotech sectors, specifically those focused on cancer therapies, diagnostics, and prevention. The firm’s long-term vision is to make cancer non-lethal within our lifetime. By backing companies at the forefront of medical discovery, Yosemite actively contributes to a future where cancer is no longer a terminal diagnosis, reshaping public health.